Novan, Inc. (NASDAQ: NOVN), a clinical–stage Biotechnology Company leveraging its expertise in nitric oxide-based therapies, has entered into a Master Services Agreement (MSA) with Catalent for supporting the development and chemistry, manufacturing and control (CMC) activities for berdazimer sodium, to be made into an intranasal...
Nemaura Medical, Inc. (NASDAQ: NMRD), a medical device technology Company developing innovative non-invasive wearable diagnostic devices, announced the official launch of BEAT®diabetes, and the availability of proBEAT™, a non-invasive, daily-wear adhesive glucose monitor. The device comes along a proBEAT™ monitor, a first-in-class non-invasive, daily-wear glucose...
BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company leveraging its signal processing technology platform, has announced the sale of three PURE EP™ Systems to St. David’s HealthCare of Austin, Texas, owned by HCA Healthcare (NYSE: HCA) and the Winner of the Malcolm Baldrige National...
Conversion Labs, Inc. (NASDAQ: CVLB) a leading direct-to-customer pharmacy and wellness brand, announced the launch of a new telehealth platform named “Veritas MD “leveraging its existing telemedicine infrastructure. The platform is aimed at meeting the increasing demand of customer for medical advice, prescription and over-the-counter health...
Nerve Stimulation is a process that involves the use of electrical stimulation technology to treat chronic pain and is categorized into Spinal Cord Stimulation and Peripheral Nerve Stimulation. These are further classified into deep brain stimulators, vagus nerve stimulators, spinal cord, sacral nerve and gastric...
CloudMD Software and Services Inc. (OTCQB: DOCRF), a leading telehealth provider in Canada, will be providing on-demand telemedicine services to the customers of one of Western Canada’s largest grocery chain, Save-On-Foods, extending their plans to set up kiosks in nine pharmacies across British Columbia. The...
Magenta Therapeutics Inc (NASDAQ: MGTA), a Company pioneering research in stem cell transplant to reset the immune system in order to combat autoimmune, blood cancers and genetic diseases, provided a development update for MGTA-145, a CXCR2 agonist that is intended as a first-line therapy for...
According to the World Health Organization (WHO), Coronavirus (CoV) is a family of viruses that cause illnesses ranging from common cold to lethal diseases such as the Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV) and a new strain of CoV named, novel...
Equillium Bio (NASDAQ: EQ), a clinical–stage biopharmaceutical Company focused on bringing innovation in form of immune-modifying therapies to treat immuno-inflammatory diseases, announced the receipt of a Study May Proceed letter from the U.S Food and Drug Administration (FDA), to evaluate the company’s lead asset itolizumab,...
Galera Therapeutics (NASDAQ: GRTX), a clinical–stage Biopharmaceutical Company aiming to redefine radiotherapy in cancer, announced positive interim results from a phase 1/2 trial of GC4419 or avasopasem manganese. An investigational, highly selective small molecule superoxide dismutase mimetic, GC4419 has the potential to convert superoxide to...
